Hypoplastic Left Heart Syndrome Clinical Trial
Official title:
Family Stress, Coping and Outcomes Following the Diagnosis of Hypoplastic Left Heart Syndrome in a Newborn
Survival for one of the most complex forms of congenital heart disease, hypoplastic left
heart syndrome (HLHS), has improved dramatically. However, little is known about family
stress, coping and outcomes following the diagnosis of HLHS. It is expected that families
face emotional, social and financial stressors. Health care professionals have a unique
opportunity to positively influence how families interpret and adapt to these stressors. The
specific aims of the study are to describe perceived stress, and coping skills utilized, in
parents of children with HLHS and their impact on family outcomes measured as well-being,
adaptation and caregiver/family quality of life, and to describe changes in stress, coping,
and adaptation and differences in perceptions of mothers versus fathers of children with HLHS
over the first 14 months of life. The Resiliency Model of Family Adjustment and Adaptation
(McCubbin, Thompson, & McCubbin, 1996) is the theoretical framework that guides this
research.
Hypotheses:
1. Family perception of stress, and coping skills utilized, will have an impact on family
outcomes measured as well-being, adaptation, and caregiver/family quality of life.
2. Variables influencing perception of stress and variables influencing family coping will
be significant predictors of family adaptation outcomes.
3. Perceptions of stress, coping skills utilized, and family adaptation outcomes will
improve during the first 14 months of life with an infant with HLHS.
4. Mothers and fathers will report different perceptions of stress, coping skills utilized,
and family adaptation outcomes during the first 14 months of life with an infant with
HLHS.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01215240 -
Prophylactic Peritoneal Dialysis Decreases Time to Achieve a Negative Fluid Balance After the Norwood Procedure
|
N/A | |
Completed |
NCT00513240 -
Erythropoetin Neuroprotection for Neonatal Cardiac Surgery
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00156455 -
Sleep Disordered Breathing in Children With Single Ventricle Physiology
|
N/A | |
Terminated |
NCT01445041 -
Safety and Feasibility Study of Umbilical Cord Blood Cells for Infants With Hypoplastic Left Heart Syndrome
|
Phase 1 | |
Recruiting |
NCT04581668 -
Impact of NAVA Ventilation on Brain Oxygenation and Perfusion in Children With Congenital Heart Disease
|
N/A | |
Completed |
NCT01736956 -
Fetal Intervention for Aortic Stenosis and Evolving Hypoplastic Left Heart Syndrome
|
N/A | |
Completed |
NCT01708863 -
A Prospective Study of Patients With Hypoplastic Left Heart Syndrome (HLHS) Following Stage II Surgical Palliation
|
||
Recruiting |
NCT03406884 -
The CHILD Trial: Hypoplastic Left Heart Syndrome Study.
|
Phase 1 | |
Not yet recruiting |
NCT06461676 -
Study of Intramyocardial Injection of Ventrix Bio Extracellular Matrix (VentriGel) to Assess the Safety and Feasibility in Pediatric Patients With Hypoplastic Left Heart Syndrome (HLHS)
|
Phase 1 | |
Active, not recruiting |
NCT03079401 -
Mesoblast Stem Cell Therapy for Patients With Single Ventricle and Borderline Left Ventricle
|
Phase 1/Phase 2 | |
Completed |
NCT02306057 -
Fluid Balance in Children Undergoing Fontan Surgery
|
N/A | |
Terminated |
NCT01107990 -
Global and Regional Myocardial Strain and Power Output In Patients With Single Ventricles Using Novel MRI Techniques
|
||
Completed |
NCT01883076 -
Safety Study of Autologous Umbilical Cord Blood Cells for Treatment of Hypoplastic Left Heart Syndrome
|
Phase 1 | |
Completed |
NCT04056416 -
Physical Activity Promotion in Children and Adolescents With Single Ventricle Physiology (MedBike)
|
N/A | |
Completed |
NCT01656941 -
Genetic Determinants of Congenital Heart Disease Outcomes
|
||
Completed |
NCT00464100 -
Near-infrared Spectroscopy (NIRS) Neurodevelopmental Outcomes
|
||
Active, not recruiting |
NCT03779711 -
Intramyocardial Injection of Autologous Umbilical Cord Blood Derived Mononuclear Cells During Surgical Repair of Hypoplastic Left Heart Syndrome
|
Phase 2 | |
Recruiting |
NCT04925024 -
Evaluation of Lomecel-B™ Injection in Patients With Hypoplastic Left Heart Syndrome (HLHS): A Phase IIb Clinical Trial.
|
Phase 2 | |
Recruiting |
NCT02781922 -
Cardiac Stem/Progenitor Cell Infusion in Univentricular Physiology (APOLLON Trial)
|
Phase 3 | |
Completed |
NCT01582529 -
SVRII Family Factors Study
|